Thompson Davis & Co’s Sensus Healthcare SRTS Stock Holding History

Thompson Davis & Co’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,000	Closed	-$83.4K	–	135
2023 Q1	$83.4K	Buy	16,000 +1,500	+10%	+$10.8K	0.11%	91
2022 Q4	$108K	Sell	14,500 -1,500	-9%	-$13.5K	0.15%	85
2022 Q3	$201K	Sell	16,000 -1,000	-6%	-$11.9K	0.27%	66
2022 Q2	$131K	Sell	17,000 -14,000	-45%	-$118K	0.21%	71
2022 Q1	$314K	Buy	31,000 +1,875	+6%	+$17.1K	0.38%	54
2021 Q4	$210K	Buy	+29,125	New	+$159K	0.17%	102

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Thompson Davis & Co's SRTS Position: Q2 2023 in Review

Thompson Davis & Co sold out of Sensus Healthcare (SRTS) in Q2 2023, closing a stake of 16,000 shares — an estimated $83.4K sold.

Thompson Davis & Co first reported a position in SRTS in Q4 2021 and held it in 6 quarters. The position peaked at $314K in Q1 2022. 49 funds tracked by Wall St. Rank hold SRTS as of Q2 2023.

Thompson Davis & Co reported no remaining Sensus Healthcare position as of Q2 2023 after selling out during the quarter.
Thompson Davis & Co sold 16,000 Sensus Healthcare shares in Q2 2023, an estimated $83.4K.
Thompson Davis & Co first reported a position in Sensus Healthcare in Q4 2021 and held it in 6 quarters.
Thompson Davis & Co's Sensus Healthcare position peaked at $314K in Q1 2022.
49 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2023.

Based on Thompson Davis & Co's 13F filing for Q2 2023, filed 13 Jul 2023.